Previous close | 35.06 |
Open | 0.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | 1,736 |
Market cap | 691.646M |
Beta (5Y monthly) | 1.10 |
PE ratio (TTM) | 0.08 |
EPS (TTM) | 4.66 |
Earnings date | 07 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
John Hancock, along with its Toronto-based parent company Manulife (NYSE: MFC), today announced a five-year, multimillion-dollar research collaboration with the Massachusetts Institute of Technology (MIT) AgeLab, a multi-disciplinary research institute that works with business, government, and NGOs, leading innovation and research to help improve the quality of life for the aging population and their loved ones. Over the next five years, Manulife/John Hancock and the MIT AgeLab will collaborate
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Manulife Investment Management (Manulife IM) announced today that it has launched two new liquid alternative funds: Manulife Alternative Opportunities Fund and Manulife Strategic Income Plus Fund. The funds are managed by Manulife Investment Management's Canadian fixed-income team and global multi-sector fixed-income team, respectively. The teams manage more than CAD$54 billion combined in assets globally.1